Advertisement
Research Article

Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment

  • Amy S Nunn mail,

    To whom correspondence should be addressed. E-mail: amycitanunn@gmail.com

    Affiliation: Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Elize M Fonseca,

    Affiliations: Department of Health Information, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan, United States of America

    X
  • Francisco I Bastos,

    Affiliation: Department of Health Information, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

    X
  • Sofia Gruskin,

    Affiliations: Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America, Program on International Health and Human Rights, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • Joshua A Salomon

    Affiliations: Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America, Harvard University Initiative for Global Health, Cambridge, Massachusetts, United States of America

    X
  • Published: November 13, 2007
  • DOI: 10.1371/journal.pmed.0040305

About the Authors

Amy S Nunn, Sofia Gruskin, Joshua A Salomon
Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
Elize M Fonseca, Francisco I Bastos
Department of Health Information, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Elize M Fonseca
Department of Health Management and Policy, University of Michigan, Ann Arbor, Michigan, United States of America
Sofia Gruskin
Program on International Health and Human Rights, Harvard School of Public Health, Boston, Massachusetts, United States of America
Joshua A Salomon
Harvard University Initiative for Global Health, Cambridge, Massachusetts, United States of America

Corresponding Author

Email: amycitanunn@gmail.com

Competing Interests

In March 2007, after original submission of this paper but before submission of the revised paper, AN accepted a position as a Corporate Relations Manager at the Global Business Coalition (GBC) on AIDS, TB and Malaria. Members of GBC include several generic and innovator pharmaceutical companies and companies that produce active pharmaceutical ingredients for pharmaceutical products. There are no other competing interests to report.

Author Contributions

ASN developed the idea for this paper and led all data collection, data analysis, and writing. EMF and FIB contributed to the data collection, analysis, and writing of this paper. SG contributed to the analysis and writing of this paper. JAS contributed to the study design, data analysis, and writing of this paper.